Pembrolizumab and nivolumab Immunotherapies Show Efficacy in Head and Neck Cancer

Pembrolizumab and nivolumab Immunotherapies Show Efficacy in Head and Neck Cancer

ScrippsHealth

4 years
433 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Tanguy Seiwert, MD of the University of Chicago discusses Pembrolizumab and nivolumab Immunotherapies and that they Show Efficacy in Head and Neck Cancer at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego. www.scrippshealth.org/cancer
Up Next Autoplay